In this review, we provide an overview of the current knowledge regarding the Bcl-2 family of proteins in breast cancer regulation and the implications of targeting these proteins as a means of enhancing breast cancer endocrine treatment. The gene discussed is BCL2; the disease is breast carcinoma.